Gregory Meyer

Gregory Meyer has extensive experience in regulatory affairs, quality assurance, and compliance in the pharmaceutical and biotechnology industries. Gregory has held various leadership roles in companies such as Premier Consulting, Zosano Pharma Inc., Skye Biologics, Inc., BioQ Pharma Incorporated, Clarity Medical Systems, Inc., Stem CentRx, Medicines360, MAP Pharma, Dey Pharma L.P, and Compliance Media. In these roles, they have developed regulatory strategies, led FDA meetings, implemented compliance plans, managed staff, and prepared submissions for regulatory approval. Gregory has also been responsible for quality assurance activities, including product release, design quality, and QMS management. Additionally, Gregory has expertise in GXP compliance, FDA inspection readiness, and regulatory filings.

Gregory Meyer attended Reed College from 1985 to 1987, where they completed their Bachelor of Arts degree in Literature and Theater. Following that, from 1990 to 1993, they worked as a Research Associate in the Department of Medicine at the University of California, San Francisco. Additional information about their education at St. John's University is not available.